Mydriasis
Information
- Disease name
- Mydriasis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT06217796 | Completed | Phase 4 | Safety and Efficacy of Fixed Combination Phenylephrine-Tropicamide for Pupil Dilation | November 28, 2023 | January 9, 2024 |
| NCT02946125 | Completed | Phase 2 | Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil | October 2016 | November 2016 |
| NCT05134974 | Completed | Phase 3 | Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (MIRA-3) | November 18, 2021 | March 29, 2022 |
| NCT05223478 | Completed | Phase 3 | Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects | December 17, 2021 | April 28, 2022 |
| NCT05880433 | Completed | The Effects of Mydriatic Eye Drops in Retinopathy of Prematurity Examinations | May 1, 2021 | November 30, 2022 | |
| NCT03751098 | Completed | Phase 3 | Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation | December 1, 2018 | January 21, 2019 |
| NCT03751631 | Completed | Phase 3 | Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation | November 15, 2018 | January 11, 2019 |
| NCT04024891 | Completed | Phase 2 | Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis | August 13, 2019 | September 17, 2019 |
| NCT04396301 | Completed | Phase 3 | Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Phaco | February 1, 2019 | September 30, 2019 |
| NCT04620213 | Completed | Phase 3 | Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis | November 18, 2020 | March 15, 2021 |
| NCT04907474 | Completed | Phase 4 | Evaluation of Pupil Dilation Speed With the MAP Dispenser | May 24, 2021 | June 3, 2021 |
| NCT05829122 | Recruiting | N/A | Sutureless Intrascleral Intraocular Lens Fixation and Modified Iris Cerclage Pupilloplasty | January 1, 2020 | December 31, 2023 |
| NCT00690222 | Terminated | N/A | Intracameral Mydriasis Versus Topical Mydriasis in Cataract Surgery | March 2008 | June 2012 |
| NCT03638726 | Unknown status | Phase 4 | Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification | September 28, 2018 | June 2019 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0011499
- MeSH unique ID (MeSH (Medical Subject Headings))
- D015878